agilon health(US:AGL) Prnewswire·2026-02-11 14:23Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against agilon health, inc. (AGL) for alleged violations of federal securities laws, with a deadline for investors to seek lead plaintiff status by March 2, 2026 [1] Summary by Relevant Sections Legal Action - A federal securities class action has been filed against agilon health, alleging that the company and its executives made false and misleading statements regarding their financial guidance and business operations [1] - The complaint claims that the defendants issued guidance for 2025 that they knew or should have known was unattainable due to industry headwinds [1] - The lawsuit also alleges that the defendants overstated the financial impact of strategic actions taken to reduce risk, leading to materially false statements about the company's prospects [1] Financial Impact - On August 4, 2025, agilon health reported its second-quarter results, indicating that industry challenges were more severe than previously anticipated, and subsequently suspended its full-year 2025 financial guidance [1] - Following this announcement, agilon health's stock price dropped by 51.5% on August 5, 2025, reflecting the market's reaction to the revised outlook [1] Class Action Participation - The lead plaintiff in the class action will be the investor with the largest financial interest who is also typical of the class members, overseeing the litigation on behalf of the group [1] - Any member of the class can apply to serve as lead plaintiff or choose to remain an absent class member, with their ability to recover not affected by this decision [1]